BackIntelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Overview

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Net Tangible Assets

Latest net tangible assets for IQMDU: $200M.

Get informed when a big investor buys or sells

+ Follow
Net Tangible Assets
$202.40M
1104.33% YoYΔ $222.55M vs prior year quarter

Peer trimmed avg / median

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Net Tangible Assets History

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) vs. peers: Net Tangible Assets Comparison

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) Net Tangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War) (IQMDU) FAQ

The latest net tangible assets for IQMDU is $200M as of December 2022. That compares with $-20M in the prior-year period — up 1104.3% year over year. Investors often review this figure alongside Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, IQMDU's net tangible assets moved from $-20M to $200M — a 1104.3% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Intelligent Medicine Acquisition - Units (1 Ord Share Class A & 1/2 War)'s operating scale or balance-sheet position.

A net tangible assets figure of $200M for IQMDU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting IQMDU's net tangible assets ($200M), review year-over-year change from $-20M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.